PAPER Hanson JE, Meilandt WJ, Gogineni A, Reynen P, Herrington J, Weimer RM, Scearce-Levie K, Zhou Q
SEARCH RESULTS
331256 RESULTS
PAPER Trigg R, Jones RW, Knapp M, King D, Lacey LA, for the DADE-2 Investigator Groups
The relationship between changes in quality of life outcomes and progression of Alzheimer's disease: results from the Dependence in AD in England 2 longitudinal study.
Int J Geriatr Psychiatry. 2014 Jun 12; PubMed: 24920081PAPER Hou XQ, Wu DW, Zhang CX, Yan R, Yang C, Rong CP, Zhang L, Chang X, Su RY, Zhang SJ, He WQ, Qu Z, Li S, Su ZR, Chen YB, Wang Q, Fang SH
Bushen‑Yizhi formula ameliorates cognition deficits and attenuates oxidative stress‑related neuronal apoptosis in scopolamine‑induced senescence in mice.
Int J Mol Med. 2014 Aug;34(2):429-39. Epub 2014 Jun 11 PubMed: 24919922PAPER Hawkins KM, Sergio LE
Visuomotor impairments in older adults at increased Alzheimer's disease risk.
J Alzheimers Dis. 2014;42(2):607-21. PubMed: 24919768PAPER Conde-Sala JL, Turró-Garriga O, Calvó-Perxas L, Vilalta-Franch J, Lopez-Pousa S, Garre-Olmo J
Three-year trajectories of caregiver burden in Alzheimer's disease.
J Alzheimers Dis. 2014;42(2):623-33. PubMed: 24919767PAPER Gil-Navarro S, Gelpi E, Lomeña F, Montagut N, Lladó A, Molinuevo JL, Sánchez-Valle R
In vivo decreased dopamine transporter uptake in corticobasal degeneration presenting with primary progressive aphasia without parkinsonism.
Eur J Neurol. 2014 Jul;21(7):e56-7. PubMed: 24919427PAPER Haque MM, Kim D, Yu YH, Lim S, Kim DJ, Chang YT, Ha HH, Kim YK
Inhibition of tau aggregation by a rosamine derivative that blocks tau intermolecular disulfide cross-linking.
Amyloid. 2014 Sep;21(3):185-90. Epub 2014 Jun 12 PubMed: 24919397PAPER Auriel E, Edlow BL, Reijmer YD, Fotiadis P, Ramirez-Martinez S, Ni J, Reed AK, Vashkevich A, Schwab K, Rosand J, Viswanathan A, Wu O, Gurol ME, Greenberg SM
Microinfarct disruption of white matter structure: a longitudinal diffusion tensor analysis.
Neurology. 2014 Jul 8;83(2):182-8. Epub 2014 Jun 11 PubMed: 24920857PAPER Miller JB, Banks SJ, Léger GC, Cummings JL
Randomized controlled trials in frontotemporal dementia: cognitive and behavioral outcomes.
Transl Neurodegener. 2014;3:12. Epub 2014 Jun 5 PubMed: 24921043PAPER Ham JH, Yi H, Sunwoo MK, Hong JY, Sohn YH, Lee PH
Cerebral microbleeds in patients with Parkinson's disease.
J Neurol. 2014 Aug;261(8):1628-35. Epub 2014 Jun 12 PubMed: 24920492PAPER Bao TH, Miao W, Han JH, Yin M, Yan Y, Wang WW, Zhu YH
Spontaneous Running Wheel Improves Cognitive Functions of Mouse Associated with miRNA Expressional Alteration in Hippocampus Following Traumatic Brain Injury.
J Mol Neurosci. 2014 Dec;54(4):622-9. Epub 2014 Jun 12 PubMed: 24920273PAPER Zokaei N, McNeill A, Proukakis C, Beavan M, Jarman P, Korlipara P, Hughes D, Mehta A, Hu MT, Schapira AH, Husain M
Visual short-term memory deficits associated with GBA mutation and Parkinson's disease.
Brain. 2014 Aug;137(Pt 8):2303-11. Epub 2014 Jun 11 PubMed: 24919969PAPER Lawson RA, Yarnall AJ, Duncan GW, Khoo TK, Breen DP, Barker RA, Collerton D, Taylor JP, Burn DJ
Quality of life and mild cognitive impairment in early Parkinson's disease: does subtype matter?
J Parkinsons Dis. 2014;4(3):331-6. PubMed: 24919824PAPER Woods RT, Nelis SM, Martyr A, Roberts J, Whitaker CJ, Markova I, Roth I, Morris R, Clare L
What contributes to a good quality of life in early dementia? Awareness and the QoL-AD: a cross-sectional study.
Health Qual Life Outcomes. 2014 Jun 11;12:94. PubMed: 24919416Inga Zerr on A Blood Test for Preclinical Prion Disease, But Will It Be Used?
COMMENT Risk of blood-born transmission of variant CJD has been a matter of concern for many years. Strong measures such as blood filtration and donor exclusion criteria have been adapted in order to minimize the risk for humans. Only few blood transfusion-relate
Current Filters
No filters selected